Entrada Therapeutics Inc (TRDA)
12.79
+0.94
(+7.93%)
USD |
NASDAQ |
May 01, 14:24
Entrada Therapeutics Total Assets (Quarterly): 469.19M for Dec. 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 469.19M |
| September 30, 2023 | 485.03M |
| June 30, 2023 | 493.98M |
| March 31, 2023 | 475.57M |
| December 31, 2022 | 252.06M |
| September 30, 2022 | 274.46M |
| Date | Value |
|---|---|
| June 30, 2022 | 295.92M |
| March 31, 2022 | 316.70M |
| December 31, 2021 | 305.83M |
| September 30, 2021 | 132.40M |
| June 30, 2021 | 143.51M |
| December 31, 2020 | 43.53M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
43.53M
Minimum
Dec 2020
493.98M
Maximum
Jun 2023
307.35M
Average
300.88M
Median
Total Assets (Quarterly) Benchmarks
| GlycoMimetics Inc | 45.32M |
| Lyell Immunopharma Inc | 750.03M |
| Candel Therapeutics Inc | 41.20M |
| Eliem Therapeutics Inc | 110.47M |
| NovaBay Pharmaceuticals Inc | 9.034M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 226.83M |
| Shareholders Equity (Quarterly) | 242.36M |
| Current Ratio | 2.329 |